clavulanic acid has been researched along with cefaclor anhydrous in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (38.46) | 18.7374 |
1990's | 10 (38.46) | 18.2507 |
2000's | 4 (15.38) | 29.6817 |
2010's | 2 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Chambers, HF; Miick, C | 1 |
Carlin, SA; Johnson, CE; Marchant, CD; Shurin, PA | 1 |
Beale, AS; Gisby, J; Wightman, BJ | 1 |
Ducroix, JP; Gaudio, F; Laurans, G; Orfila, J | 1 |
Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
Denis, P; Gehanno, P; Gojon, D; Hoareau, J; Jacquet, P; Kosowski, A; Pascarel, J; Taillebe, M | 1 |
Braschi, R; Moreo, G; Nani, M; Remotti, G; Sardi, C | 1 |
Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
Chapin, KC; Doern, GV | 1 |
Gezelius, L; Liljequist, BO | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Iravani, A; Richard, GA | 1 |
Carlin, SA; Feinstein, JC; Flexon, P; Fulton, D; Johnson, CE; Marchant, CD; Murdell-Panek, D; Shurin, PA; Van Hare, GF | 1 |
Gurwith, D; Gurwith, MJ; Stein, GE | 1 |
Pien, FD | 1 |
Cole, M; Farmer, T; Reading, C | 1 |
Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
Jradeh, M; Shihab, Z; Uwaydah, M | 1 |
Esparcia Navarro, M; GarcĂa Callejo, FJ; Orts Alborch, MH; Pardo Mateu, L; Velert Vila, MM | 1 |
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
8 trial(s) available for clavulanic acid and cefaclor anhydrous
Article | Year |
---|---|
Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1992 |
Short-course cefotaxime compared with five-day co-amoxyclav in acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Cefaclor; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media | 1990 |
[Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Asthma; Bronchitis; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1988 |
Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.
Topics: Adolescent; Adult; Amoxicillin; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Penicillin Resistance; Random Allocation; Rectum; Urinary Tract Infections; Urogenital System | 1986 |
A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Cefaclor; Cephalexin; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Infant; Male; Neisseria; Otitis Media; Otitis Media with Effusion; Random Allocation; Streptococcus pneumoniae | 1986 |
Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.
Topics: Adult; Amoxicillin; Ampicillin; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Penicillin Resistance; Prospective Studies; Urinary Tract Infections | 1983 |
Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans | 1983 |
[Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Clavulanic Acid; Female; Humans; Male; Maxillary Sinusitis; Otitis Media; Penicillins; Pharyngitis; Tonsillitis | 1998 |
18 other study(ies) available for clavulanic acid and cefaclor anhydrous
Article | Year |
---|---|
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptides.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding, Competitive; Carrier Proteins; Cefaclor; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Electrophoresis, Gel, Two-Dimensional; Hexosyltransferases; Methicillin; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1992 |
Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Female; Humans; Mice; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 1991 |
[In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefuroxime; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Moraxella catarrhalis | 1991 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Cefaclor; Cefuroxime; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseriaceae; Penicillin G | 1986 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Kinetics; Staphylococcus aureus; Time Factors | 1983 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon.
Topics: Amoxicillin; Cefaclor; Ceftriaxone; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Lebanon; Penicillin G; Streptococcus pneumoniae; Tetracycline | 1996 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |